Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Concurrent Session 9: Emergent Themes from the Study of Resistance to Targeted Therapeutics

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Concurrent Session 9: Emergent Themes from the Study of Resistance to Targeted Therapeutics
Early lessons from initial acquired resistance to TRK inhibitors
David M Hyman
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 29, 2019 4:15 PM-6:00 PM
Concurrent Session 9: Emergent Themes from the Study of Resistance to Targeted Therapeutics
Lessons learnt in clinic from resistance to first generation molecular targeted therapies in solid cancers
Ahmad Awada
Jules Bordet Institute, Brussels, Belgium
from 2019 Molecular Targets and Cancer Therapeutics conference on October 29, 2019 4:15 PM-6:00 PM
Concurrent Session 9: Emergent Themes from the Study of Resistance to Targeted Therapeutics
  •  
  • Permission not
    granted for presentation
  •  
  •  
Spatially resolved profiling of the tumor-immune microenvironment during neoadjuvant HER2-targeted therapy predicts response
Christina Curtis
Stanford University, Stanford, CA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 29, 2019 4:15 PM-6:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3